Connect with us

Health

Novel Combinations Excite the R/R Hodgkin Lymphoma Treatment Landscape – Targeted Oncology

While the treatment of relapsed or refractory Hodgkin lymphoma has seen novel approaches in recent years improving outcomes for many patients, high-risk patients…

Published

on

Article feature image

While the treatment of relapsed or refractory (R/R) Hodgkin lymphoma (HL) has seen novel approaches in recent years improving outcomes for many patients, high-risk patients develop progressive disease and have limited treatment options.1
Two studies presented during the 62nd American Society of Hematology Annual Meeting and Exposition explored new therapeutic strategies for this patient population. First, results from a phase 2 study (NCT04052997) suggest that camidanlumab tesirine (ADCT-301) can…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Researchers find a way to mend broken hearts – Monash University
Article feature image
Could virosome-based nanovaccines be a promising new approach to preventing viral diseases? – News-Medical.Net